Issue: Volume XX, No. 16 - December 2, 2013

Charting Your Lab’s Course for 2014

WITHOUT QUESTION, CLINICAL LABS AND PATHOLOGY GROUPS will be confronted with tough challenges during 2014. Across the nation, lab executives and pathologists tell us that it is no longer “business as usual.” What I find most interesting about the feedback pouring into our offices is that the Affordable Care Act is not a factor for …

Charting Your Lab’s Course for 2014 Read More »

ACLA, CAP Comment on Final 2014 Medicare Rules

CEO SUMMARY: On November 27, as the nation prepared for the Thanksgiving holiday, the federal Centers for Medicare & Medicaid Services (CMS) announced the long-awaited final rules for 2014. Early analysis of the 1,300 pages of rules CMS released indicates that the agency moderated one of its proposals to cut back what pathologists and clinical …

ACLA, CAP Comment on Final 2014 Medicare Rules Read More »

Lab Companies’ IPOs Go Two-for-Three in November

CEO SUMMARY: This fall, a parade of molecular and genetic test companies moved forward with initial public offerings (IPOs) of their stock. In September, Foundation Medicine raised $106 million from its IPO. Encouraged by this success, three different companies proceeded with IPOs during November. The IPOs of Veracyte and Oxford Immunotec raised $58 million and …

Lab Companies’ IPOs Go Two-for-Three in November Read More »

Frederick Sanger Dies at Age 95, Hailed as Father of Genomics

EVERY DAY, ACROSS THE GLOBE, labs perform testing using Sanger sequencing and other fundamental techniques of proteomics and genomics pioneered and developed by Frederick Sanger, who died last month at the age of 95. Sanger is considered one of the giants in biochemistry. He was one of only three people awarded two Nobel prizes in …

Frederick Sanger Dies at Age 95, Hailed as Father of Genomics Read More »

Lab’s Patient-Centric Approach Collects Overdue Money in PSCs

CEO SUMMARY: At Sonora Quest Laboratories (SQL), the ‘Voice of the Customer’ is guiding the organization’s evolution from physician-centric to patient-centric. It was quickly recognized that an effective enterprise master patient index (EMPI) was essential. One patient-centric service that SQL is in the midst of deploying is the capability to collect overdue money owed it …

Lab’s Patient-Centric Approach Collects Overdue Money in PSCs Read More »

Georgia Lab Pays Docs For Urine Test Referrals

CEO SUMMARY: Physicians could make $400 or more per sample, according to one physician. But under the federal Stark Law, the federal Anti-kickback Law, and under Florida state law, physicians and other healthcare providers are prohibited from referring patients or doing work for kickbacks and from splitting fees with other healthcare providers, according to one …

Georgia Lab Pays Docs For Urine Test Referrals Read More »

Dark Daily

December 2, 2013 “Intelligence: Late-Breaking Lab News”

Despite the continuing cutbacks in reimbursement for lab testing, some professional investors still see opportunity in this market sector. On November 13, Genova Diagnostics, Inc., of Asheville, North Carolina, was acquired by Levine Leichtman Capital Partners and “members of management.” The sellers were Nautic Partners and Ferrer Freeman & Company, LLC. Genova’s CEO is Ted …

December 2, 2013 “Intelligence: Late-Breaking Lab News” Read More »

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.